Litcius/Paper detail

Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia

Ari Pelcovits, Jozal Moore, Brianna R. Bakow, Rabin Niroula, Pamela Egan, John L. Reagan

2021Supportive Care in Cancer23 citationsDOI

Topics & Concepts

VenetoclaxMedicineTumor lysis syndromeMyeloid leukemiaInternal medicineOncologyLeukemiaChemotherapyChronic lymphocytic leukemiaMethemoglobinemia and Tumor Lysis SyndromeAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia research
Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia | Litcius